- Filed
- Mar 4, 2021 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2020 · Feb 25, 2021 | 116.66M sh |
| Shares Diluted | FY 2020 · Dec 31, 2020 | 111.05M sh |
| Shares Diluted | FY 2020 · Dec 31, 2019 | 100.47M sh |
| Capex | FY 2020 · Dec 31, 2020 | $15K |
| Capex | FY 2020 · Dec 31, 2019 | $96K |
| Operating Cash Flow | FY 2020 · Dec 31, 2020 | −$677K |
| Operating Cash Flow | FY 2020 · Dec 31, 2019 | −$5.17M |
| Cash And Equivalents | FY 2020 · Dec 31, 2020 | $1.34M |
| Cash And Equivalents | FY 2020 · Dec 31, 2019 | $2.03M |
| Stockholders Equity | FY 2020 · Dec 31, 2020 | −$81.09M |
| Stockholders Equity | FY 2020 · Dec 31, 2019 | −$72.06M |
| Stockholders Equity | FY 2020 · Dec 31, 2018 | −$62.96M |
| Current Liabilities | FY 2020 · Dec 31, 2020 | $2.94M |
| Current Liabilities | FY 2020 · Dec 31, 2019 | $4.22M |
| Total Liabilities | FY 2020 · Dec 31, 2020 | $93.27M |
| Total Liabilities | FY 2020 · Dec 31, 2019 | $91.48M |
| Current Assets | FY 2020 · Dec 31, 2020 | $7.06M |
| Current Assets | FY 2020 · Dec 31, 2019 | $9.28M |
| Total Assets | FY 2020 · Dec 31, 2020 | $12.18M |
| Total Assets | FY 2020 · Dec 31, 2019 | $19.42M |
| Eps Diluted | FY 2020 · Dec 31, 2020 | −$0.08 |
| Eps Diluted | FY 2020 · Dec 31, 2019 | −$0.10 |
| Eps Basic | FY 2020 · Dec 31, 2020 | −$0.08 |
| Eps Basic | FY 2020 · Dec 31, 2019 | −$0.10 |
| Net Income | FY 2020 · Dec 31, 2020 | −$9.17M |
| Net Income | FY 2020 · Dec 31, 2019 | −$10.23M |
| Operating Income | FY 2020 · Dec 31, 2020 | −$5.87M |
| Operating Income | FY 2020 · Dec 31, 2019 | −$5.65M |
| Cost Of Revenue | FY 2020 · Dec 31, 2020 | $45.82M |
| Cost Of Revenue | FY 2020 · Dec 31, 2019 | $56.48M |
| Revenue | FY 2020 · Dec 31, 2020 | $51.35M |
| Revenue | FY 2020 · Dec 31, 2019 | $63.47M |